Pulmonary Vein News and Research

RSS

Experts recommend shortening the blanking period after atrial fibrillation ablation

New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.

17 Apr 2024

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort.

8 Jan 2024

Pulsed field ablation safe and effective for women with atrial fibrillation

Women with atrial fibrillation (AF) undergoing a procedure called pulsed field ablation (PFA) have just as good outcomes as men with AF undergoing the same procedure, according to a large-scale international study led by the Icahn School of Medicine at Mount Sinai.

1 Nov 2023

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

MRI-guided ablation improves outcomes for younger AFib patients, study shows

Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.

25 Aug 2023

Innovative three-step ablation approach holds promise for patients with persistent atrial fibrillation

An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation compared to pulmonary vein isolation (PVI) alone, according to late-breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.

18 Apr 2023

Extended ECG monitoring of patients with hypertrophic cardiomyopathy detects more arrhythmias

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.

17 Apr 2023

Updated expert consensus statement on transcatheter left atrial appendage closure released

Today, the Society for Cardiovascular Angiography & Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC).

27 Mar 2023

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.

From Biosense Webster Inc. 17 Oct 2022

Simplicity is key when it comes to ablation, global AFib study finds

Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the simple approach is usually best when it comes to ablation, a procedure where physicians destroy or ablate cardiac tissue to correct irregular heart rhythms.

21 Jun 2022

Researchers analyze similarities and differences of CT features between heart failure and COVID-19

In a new publication from Cardiovascular Innovations and Applications; Zhaowei Zhu, Jianjun Tang, Xiangping Chai and colleagues from Central South University, Changsha, Hunan, China analyse the similarities and differences of CT features between COVID-19 pneumonia and heart failure.

20 Aug 2021

Researchers receive NIH grant to explore how imaging can help predict atrial fibrillation recurrence

A team led by researchers from Cleveland Clinic and Case Western Reserve University have received a $2.95 million grant over four years from the National Institutes of Health to explore how imaging can be used to predict the risk of atrial fibrillation recurrence.

12 Jul 2021

Non-contact IR thermometers fail for COVID-19 temperature screening, say physicians

While a fever is one of the most common symptoms for people who get sick with COVID-19, taking one's temperature is a poor means of screening who is infected with the SARS-CoV-2 virus that causes the disease, and more importantly, who might be contagious.

15 Dec 2020

Simplified catheter ablation could slash waiting lists for atrial fibrillation patients

A day case catheter ablation procedure which includes only the bare essentials and delivers the same outcomes could slash waiting lists for atrial fibrillation patients, according to late-breaking results from the AVATAR-AF trial presented today at EHRA 2019, a European Society of Cardiology congress.

18 Mar 2019

Biosense Webster treats first patient in U.S. IDE study of HELIOSTAR RF Balloon Ablation Catheter

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its STELLAR U.S. Investigational Device Exemption study.

From Johnson & Johnson 4 Dec 2018

Botulinum toxin injections show promise to suppress postoperative atrial fibrillation

Postoperative atrial fibrillation is a common complication, affecting one quarter to one half of all patients following cardiac surgery.

28 Nov 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled and treated the first patient in its SHINE clinical study in Europe.

From Johnson & Johnson 15 Mar 2018

Penn researchers find AF ablation to be safe and effective for CHD patients

Congenital heart disease (CHD) includes a range of defects that occur in the heart which patients are born with, such as a hole in the heart's wall, a leaky valve or even an inversion in the heart's orientation. CHD was once a severe condition often resulting in early death, but now, more and more CHD patients are living long and healthy lives.

15 May 2017

UI Health first in the Midwest to offer improved minimally invasive treatment for atrial fibrillation

The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.

11 May 2017